Thermoplastic Polymer Nucleating Agents for Shrinkage Control

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current nucleating agents for thermoplastic polymers often fail to achieve a desirable combination of high peak polymer recrystallization temperature, low isotropic shrinkage, and high stiffness, leading to issues such as excessive and uneven shrinkage in molded parts.

Innovation Solution

The use of specific nucleating agents conforming to Formula (I) or Formula (II) in thermoplastic polymer compositions, particularly with polyethylene, which provide a compound that enhances crystallization temperature and stiffness while minimizing isotropic shrinkage.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Temperature

If conventional nucleating agents are used to increase peak polymer recrystallization temperature, then crystallization temperature is improved, but shrinkage becomes excessive and anisotropic

Engineering Contradiction:
Improvepeak polymer recrystallization temperatureVSAvoidshrinkage uniformity
Core Design Contradiction:
TemperatureVSManufacturing precision

Solution Approach 1:

The patent applies parameter changes by modifying the chemical structure of nucleating agents from conventional types to specific compounds with formulas (I) and (II) containing metal cations (M1) and controlled substituents (R1-R6). This structural parameter change enables the nucleating agent to promote crystallization at higher temperatures while controlling the crystallization kinetics to achieve more uniform shrinkage behavior in molded parts.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent employs composite materials by combining the thermoplastic polymer with specifically designed nucleating agent compounds that contain metal cations (such as zinc, calcium, or magnesium) coordinated with organic ligands. This composite approach creates a synergistic effect where the metal cation provides structural templates for crystal formation while the organic ligands control the nucleation rate, achieving both high recrystallization temperature and uniform shrinkage.

Inventive Principle:
Principle #40Composite materials

2Productivity

If rapid crystallization rate is induced by nucleating agent, then processing cycle time is reduced, but shrinkage becomes excessive and anisotropic

Engineering Contradiction:
Improveprocessing cycle timeVSAvoidshrinkage uniformity
Core Design Contradiction:
ProductivityVSManufacturing precision

Solution Approach 1:

The patent modifies the kinetic parameters of crystallization by using nucleating agents with specific metal cation-ligand compositions. The controlled substituents (R1-R6) and metal cation valence (y) in formulas (I) and (II) adjust the nucleation density and crystal growth rate to achieve optimal processing speeds with uniform shrinkage.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent applies local quality by creating specific local environments around metal cation centers where crystallization is initiated. The organic ligands surrounding the metal cation (M1) with specific substituent patterns (R1-R6) create localized nucleation sites that promote uniform crystal growth in all directions, preventing anisotropic shrinkage while maintaining rapid overall crystallization.

Inventive Principle:
Principle #3Local quality

3Temperature

If conventional nucleating agents are used, then crystallization temperature is increased, but stiffness is not sufficiently improved

Engineering Contradiction:
Improvepeak polymer recrystallization temperatureVSAvoidstiffness
Core Design Contradiction:
TemperatureVSStrength

Solution Approach 1:

The patent uses composite nucleating agents combining metal cations (zinc, calcium, magnesium) with specific organic ligands in formulas (I) and (II). This composite structure creates more effective crystal nucleation sites that produce higher crystal density and better crystal morphology, simultaneously achieving higher recrystallization temperatures and improved stiffness in the molded parts.

Inventive Principle:
Principle #40Composite materials

Solution Approach 2:

The patent changes the chemical parameters of the nucleating agent by introducing metal cations with different valences (y) and controlling the substituents (R1-R6). This parameter optimization enhances the interaction between the nucleating agent and polymer chains, promoting more extensive crystallization and higher degree of crystallinity, which directly improves stiffness while maintaining high recrystallization temperature.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The described nucleating agents and thermoplastic polymer compositions achieve higher peak polymer recrystallization temperatures and higher stiffness with more isotropic shrinkage compared to non-nucleated and other nucleated thermoplastic polymers, enabling improved processing and reduced post-molding deformation.

Implementation Method 1

These nucleating agents generally function by forming nuclei or providing sites for the formation and/or growth of crystals in the thermoplastic polymer as it solidifies from a molten state

Methodology Applied
Scientific EffectNucleation: Nucleation

Implementation Method 2

a particular nucleating agent may be very effective at increasing the peak polymer recrystallization temperature of a thermoplastic polymer

Methodology Applied
Scientific EffectCrystallisation: Crystallisation

Data Source

PatentEP2488579B1Thermoplastic polymer composition
Publication Date: 2017.05.03 MILLIKEN & CO
  • EP2488579B1 patent drawing
  • EP2488579B1 patent drawing
  • EP2488579B1 patent drawing

AI summary

A thermoplastic polymer composition comprises a thermoplastic polymer and a nucleating agent. The nucleating agent comprises a compound conforming to the structure of Formula (I) or Formula (II).